drug discovery
AI & Automation
Closed-Loop AI Labs: How Pharma Is Automating the Entire Discovery Cycle
ALGERIATECH Editorial
May 15, 2026
⚡ Key Takeaways NVIDIA and Eli Lilly are jointly investing up to $1 billion over five years to build a...
AI & Automation
Novo Nordisk and OpenAI: When a Pharma Giant Goes All-In on AI Across Every Function
ALGERIATECH Editorial
May 9, 2026
⚡ Key Takeaways Novo Nordisk ($46.8B revenue, 69,500 employees) announced a full-company AI partnership with OpenAI on April 14, 2026,...
Startups
Anthropic Buys Coefficient Bio for $400M: A Sub-10-Person Stealth Startup Becomes Anthropic’s Drug Discovery Engine
ALGERIATECH Editorial
April 26, 2026
⚡ Key Takeaways Anthropic acquired stealth biotech AI startup Coefficient Bio in an all-stock $400M deal on April 3, 2026...
AI & Automation
Eli Lilly’s LillyPod: 1,016 GPUs and Pharma’s AI Supercomputer Gamble
ALGERIATECH Editorial
April 2, 2026
⚡ Key Takeaways LillyPod’s 1,016 NVIDIA Blackwell Ultra GPUs deliver over 9,000 petaflops of AI performance — each single GPU...
AI & Automation
AI in Healthcare: From Diagnostics to Drug Discovery – The Revolution Happening Now
ALGERIATECH Editorial
December 8, 2025
Introduction Of all the domains where AI is making a material difference in human lives, healthcare stands apart. In 2022, DeepMind's AlphaFold 2 predicted the 3D structure of virtually every known protein — approximately 200 million structures.
